Basecamp Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Basecamp Wealth Advisors's ABBV Position: Q2 2026 in Review
Basecamp Wealth Advisors reduced its AbbVie (ABBV) stake by 0.03% in Q2 2026, selling an estimated $430 and leaving 7,722 shares worth $1.94M. The position accounts for 0.36% of the portfolio, ranked #31.
Basecamp Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,180 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Basecamp Wealth Advisors held 7,722 shares of AbbVie worth $1.94M as of Q2 2026.
- Basecamp Wealth Advisors sold 2 AbbVie shares in Q2 2026, an estimated $430.
- AbbVie made up 0.36% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #31 holding.
- Basecamp Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
- 4,180 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.